Rock Springs Capital Management LP Atea Pharmaceuticals, Inc. Transaction History

Rock Springs Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.67 - $44.59 $5.75 Million - $33.5 Million	-750,307 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$21.33 - $35.06 $870,818 - $1.43 Million	-40,826 Reduced 5.16%	750,307 $26.3 Million
Q2 2021 Aug 16, 2021	SELL	$19.22 - $59.08 $17.4 Million - $53.4 Million	-903,770 Reduced 53.32%	791,133 $17 Million
Q1 2021 May 17, 2021	SELL	$41.42 - $88.44 $103,550 - $221,100	-2,500 Reduced 0.15%	1,694,903 $105 Million
Q4 2020 Feb 16, 2021	BUY	$26.36 - $41.78 $44.7 Million - $70.9 Million	1,697,403 New	1,697,403 $70.9 Million

112

52.4M

900

126K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $283M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.